Tag: Eli Lilly and Co.

Chesterbrook's Aclaris Therapeutics Enters $31.5 Million Royalty, Milestone Payments Deal

July 23, 2024

Chesterbrook-based Aclaris Therapeutics has agreed to sell $31.5 million of its future Eli Lilly and Co. royalty and milestone payments to a Canadian…